Medically Tailored Meals + Lifestyle Intervention for HIV and Type 2 Diabetes
(FAME-H Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how specialized meal plans and lifestyle changes can assist people living with HIV and type 2 diabetes, or those at risk, especially if they face food insecurity. Participants will receive meals tailored to their medical needs and lifestyle coaching over the phone to determine if this combination improves health more than receiving meals alone. This study suits individuals diagnosed with HIV, those with type 2 diabetes or at risk, and those experiencing food insecurity affecting daily life. As an unphased trial, it offers a unique opportunity to contribute to research that could lead to better health strategies for managing HIV and diabetes.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are using medications that affect blood sugar intermittently, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that meals specifically designed for medical needs and focused lifestyle changes are generally safe. Studies have found that providing these meals to patients with diabetes not only improves their diet and access to food but also reduces hospital visits by up to 50%. Using these meals and lifestyle changes together is well-tolerated, with no major side effects reported in past studies. These results provide strong evidence for the safety of this treatment approach.12345
Why are researchers excited about this trial?
Researchers are excited about the Medically Tailored Meals (MTM) combined with Intensive Lifestyle Intervention (ILI) for HIV and Type 2 Diabetes because it takes a personalized approach to treatment. Unlike standard care, which often involves medication management and general dietary advice, this treatment provides weekly home-delivered meals specifically tailored to each individual's medical needs. It also includes a comprehensive 20-session telephone lifestyle program, which helps participants build skills and behaviors to sustain health benefits even after the intervention ends. This holistic method not only targets nutrition but also emphasizes long-term lifestyle changes, offering a unique and potentially more effective way to manage these conditions.
What evidence suggests that this trial's treatments could be effective for HIV and Type 2 Diabetes?
Research has shown that specially prepared meals, when combined with a focused lifestyle program, can greatly improve health for people with HIV and Type 2 Diabetes (T2DM). In this trial, participants in one arm will receive Medically Tailored Meals (MTM) combined with an Intensive Lifestyle Intervention (ILI), which includes weekly home meal delivery and a 20-session telephone lifestyle change program. Studies have found that such combined interventions can reduce hospital visits by up to 50% and lower overall healthcare use. One study showed that these meals significantly improved patients' diet quality, increasing their Healthy Eating Index score by 31.4 points. Additionally, providing these meals to diabetic patients improved their diet and food security. These findings suggest that using these meals along with lifestyle changes could effectively manage both HIV and T2DM, especially for those who struggle to get enough food.12346
Who Is on the Research Team?
Seth A Berkowitz, MD, MPH
Principal Investigator
University of North Carolina, Chapel Hill
Are You a Good Fit for This Trial?
Adults over 18, who speak English and are not planning to move for a year, can join this trial if they're food insecure with HIV and Type 2 Diabetes or at high risk of it. They must be able to control their diet and consent to all study activities. Pregnant individuals, those in similar studies recently, with certain illnesses or drug misuse cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive medically tailored meals and intensive lifestyle intervention or standard nutrition education for 12 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- MTM + ILI
- Standard MTM
MTM + ILI is already approved in United States for the following indications:
- HIV
- Type 2 Diabetes Mellitus
- Food Insecurity
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Community Servings
Collaborator
Community Servings
Collaborator
Massachusetts General Hospital
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator